Editing Heart (TRPM7)

{{tp|p=37899484|t=2023. Identification of RNA reads encoding different channels in isolated rat ventricular myocytes and the effect of cell stretching on L-type Ca(2+)current.|pdf=|usr=}}{{37899484}}
{{tp|p=36499188|t=2022. Detection of TRPM6 and TRPM7 Proteins in Normal and Diseased Cardiac Atrial Tissue and Isolated Cardiomyocytes.|pdf=|usr=}}{{36499188}}
{{tp|p=34326388|t=2021. Evidence for the expression of TRPM6 and TRPM7 in cardiomyocytes from all four chamber walls of the human heart.|pdf=|usr=}}{{34326388}}
{{tp|p=35204269|t=2022. The Beneficial Effect of Carvacrol in HL-1 Cardiomyocytes Treated with LPS-G: Anti-Inflammatory Pathway Investigations.|pdf=|usr=}}{{35204269}}
{{tp|p=34331987|t=2021. Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.|pdf=|usr=}}{{34331987}}
{{tp|p=34096318|t=2021. Magnesium Deficiency Causes a Reversible, Metabolic, Diastolic Cardiomyopathy.|pdf=|usr=}}{{34096318}}
{{tp|p=33153064|t=2020. Dietary Mg(2+) Intake and the Na(+)/Mg(2+) Exchanger SLC41A1 Influence Components of Mitochondrial Energetics in Murine Cardiomyocytes.|pdf=|usr=}}{{33153064}}
{{tp|p=32641948|t=2019. Carvacrol Ameliorates Pathological Cardiac Hypertrophy in Both In-vivo and In-vitro Models.|pdf=|usr=}}{{32641948}}
{{tp|p=31572181|t=2019. Carvacrol Attenuates Diabetic Cardiomyopathy by Modulating the PI3K/AKT/GLUT4 Pathway in Diabetic Mice.|pdf=|usr=}}{{31572181}}
{{tp|p=35277059|t=2022. An Emerging Role of Defective Copper Metabolism in Heart Disease.|pdf=|usr=}}{{35277059}}
{{tp|p=28656113|t=2017. Cardiac Dysrhythmias and Neurological Dysregulation: Manifestations of Profound Hypomagnesemia.|pdf=|usr=}}{{28656113}}
{{tp|p=37979024|t=2023. Hypergravity Increases the Number of Gene Transcripts of Mechanically Gated and Mechanosensitive Ion Channels in Rat Ventricular Cardiomyocytes.|pdf=|usr=}}{{37979024}}
{{tp|p=35099165|t=2022. Unraveling the Cardiac Effects Induced by Carvacrol in Spontaneously Hypertensive Rats: Involvement of Transient Receptor Potential Melastatin Subfamily 4 and 7 Channels.|pdf=|usr=}}{{35099165}}
{{tp|p=34644560|t=2023. Viewpoints on the Role of Transient Receptor Potential Melastatin Channels in Cardiovascular System and Disease: A Systematic Review.|pdf=|usr=}}{{34644560}}
{{tp|p=34559972|t=2022. Cardioprotective effect of fingolimod against calcium paradox-induced myocardial injury in the isolated rat heart.|pdf=|usr=}}{{34559972}}
{{tp|p=32924998|t=2021. Protective effect of inhibiting TRPM7 expression on hypoxia post-treatment H9C2 cardiomyocytes.|pdf=|usr=}}{{32924998}}
{{tp|p=32503408|t=2020. The TRPM7 Channel in the Nervous and Cardiovascular Systems.|pdf=|usr=}}{{32503408}}
{{tp|p=32337263|t=2020. Effect of Carvacrol, TRP Channels Modulator, on Cardiac Electrical Activity.|pdf=|usr=}}{{32337263}}
{{tp|p=32325152|t=2020. Quantitative proteomics characterization of acutely isolated primary adult rat cardiomyocytes and fibroblasts.|pdf=|usr=}}{{32325152}}
{{tp|p=29909547|t=2019. Modulation of Mg(2+) influx and cytoplasmic free Mg(2+) concentration in rat ventricular myocytes.|pdf=|usr=}}{{29909547}}
{{tp|p=29511803|t=2018. TRPM7 regulates angiotensin II-induced sinoatrial node fibrosis in sick sinus syndrome rats by mediating Smad signaling.|pdf=|usr=}}{{29511803}}
{{tp|p=29108260|t=2017. Angiotensin-converting enzyme-2 overexpression improves atrial electrical remodeling through TRPM7 signaling pathway.|pdf=|usr=}}{{29108260}}
{{tp|p=27818786|t=2016. TRPM7 is down-regulated in both left atria and left ventricle of ischaemic cardiomyopathy patients and highly related to changes in ventricular function.|pdf=|usr=}}{{27818786}}
{{tp|p=15272039|t=2004. Magnesium-inhibited, TRPM6/7-like channel in cardiac myocytes: permeation of divalent cations and pH-mediated regulation.|pdf=|usr=}}{{15272039}}
{{tp|p=19100096|t=2008. [Increased expression of transient receptor potential melastatin 7 in mouse cardiac fibroblasts post myocardial infarction].|pdf=|usr=}}{{19100096}}
{{tp|p=24039880|t=2013. Magnesium homeostasis in cardiac myocytes of Mg-deficient rats.|pdf=|usr=}}{{24039880}}
{{tp|p=23878236|t=2013. Ion channel-kinase TRPM7 is required for maintaining cardiac automaticity.|pdf=|usr=}}{{23878236}}
{{tp|p=22891975|t=2012. Characterization of Mg(2)(+)-regulated TRPM7-like current in human atrial myocytes.|pdf=|usr=}}{{22891975}}
{{tp|p=22802050|t=2012. Evidence for functional expression of TRPM7 channels in human atrial myocytes.|pdf=|usr=}}{{22802050}}
{{tp|p=38020917|t=2023. Cardioprotective effects of Moku-boi-to and its impact on AngII-induced cardiomyocyte hypertrophy.|pdf=|usr=}}{{38020917}}
{{tp|p=35859594|t=2022. The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.|pdf=|usr=}}{{35859594}}
{{tp|p=34434970|t=2021. Electrophysiological and Molecular Mechanisms of Sinoatrial Node Mechanosensitivity.|pdf=|usr=}}{{34434970}}
{{tp|p=31281820|t=2019. TRP Channels Mediated Pathological Ca(2+)-Handling and Spontaneous Ectopy.|pdf=|usr=}}{{31281820}}
{{tp|p=29057165|t=2017. Mechanisms of Fibroblast Activation in the Remodeling Myocardium.|pdf=|usr=}}{{29057165}}
{{tp|p=23448358|t=2013. Function and fate of myofibroblasts after myocardial infarction.|pdf=|usr=}}{{23448358}}
{{tp|p=17082763|t=2006. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.|pdf=|usr=}}{{17082763}}
{{tp|p=35185581|t=2022. Transcription Factors Involved in the Development and Prognosis of Cardiac Remodeling.|pdf=|usr=}}{{35185581}}
{{tp|p=34489714|t=2021. An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update.|pdf=|usr=}}{{34489714}}
{{tp|p=34149453|t=2021. Heterogeneity and Remodeling of Ion Currents in Cultured Right Atrial Fibroblasts From Patients With Sinus Rhythm or Atrial Fibrillation.|pdf=|usr=}}{{34149453}}
{{tp|p=30881310|t=2019. TRP Channels: Current Perspectives in the Adverse Cardiac Remodeling.|pdf=|usr=}}{{30881310}}
{{tp|p=37240147|t=2023. Calcium Homeostasis, Transporters, and Blockers in Health and Diseases of the Cardiovascular System.|pdf=|usr=}}{{37240147}}
{{tp|p=29137144|t=2017. Impact of Labile Zinc on Heart Function: From Physiology to Pathophysiology.|pdf=|usr=}}{{29137144}}
{{tp|p=24232452|t=2013. The NO/ONOO-cycle as the central cause of heart failure.|pdf=|usr=}}{{24232452}}
{{tp|p=35597275|t=2022. Necroptosis in heart disease: Molecular mechanisms and therapeutic implications.|pdf=|usr=}}{{35597275}}
{{tp|p=23441631|t=2013. Mechanobiology in cardiac physiology and diseases.|pdf=|usr=}}{{23441631}}
{{tp|p=37438528|t=2023. Spatially resolved multiomics of human cardiac niches.|pdf=|usr=}}{{37438528}}
{{tp|p=31253831|t=2019. Quantitative proteomics and single-nucleus transcriptomics of the sinus node elucidates the foundation of cardiac pacemaking.|pdf=|usr=}}{{31253831}}
{{tp|p=37914708|t=2023. Age-dependent contribution of intrinsic mechanisms to sinoatrial node function in humans.|pdf=|usr=}}{{37914708}}
{{tp|p=26713556|t=2016. A review of the literature on cardiac electrical activity between fibroblasts and myocytes.|pdf=|usr=}}{{26713556}}
{{tp|p=25661032|t=2015. Atrial remodeling, fibrosis, and atrial fibrillation.|pdf=|usr=}}{{25661032}}
{{tp|p=26776094|t=2016. The Living Scar--Cardiac Fibroblasts and the Injured Heart.|pdf=|usr=}}{{26776094}}
{{tp|p=C7123129|t=2018. Cardiovascular Disease: An Introduction.|pdf=|usr=}}{{C7123129}}
{{tp|p=35336788|t=2022. Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications.|pdf=|usr=}}{{35336788}}
{{tp|p=33017571|t=2021. Pharmacologic Approach to Sinoatrial Node Dysfunction.|pdf=|usr=}}{{33017571}}
{{tp|p=29906228|t=2018. Changes in cardiac resident fibroblast physiology and phenotype in aging.|pdf=|usr=}}{{29906228}}
{{tp|p=23790385|t=2013. Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation.|pdf=|usr=}}{{23790385}}
{{tp|p=35626694|t=2022. Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD.|pdf=|usr=}}{{35626694}}
{{tp|p=33135058|t=2021. Cardiac fibrosis.|pdf=|usr=}}{{33135058}}
{{tp|p=27340270|t=2016. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.|pdf=|usr=}}{{27340270}}
{{tp|p=37187923|t=2023. miR-135a Regulates Atrial Fibrillation by Targeting Smad3.|pdf=|usr=}}{{37187923}}
{{tp|p=36006872|t=2022. Tbx18 Orchestrates Cytostructural Transdifferentiation of Cardiomyocytes to Pacemaker Cells by Recruiting the Epithelial-Mesenchymal Transition Program.|pdf=|usr=}}{{36006872}}
{{tp|p=34445449|t=2021. Modulation of the Cardiac Myocyte Action Potential by the Magnesium-Sensitive TRPM6 and TRPM7-like Current.|pdf=|usr=}}{{34445449}}
{{tp|p=31315301|t=2019. TRP Channels Expression Profile in Human End-Stage Heart Failure.|pdf=|usr=}}{{31315301}}
{{tp|p=28839241|t=2017. Leukocyte TRP channel gene expressions in patients with non-valvular atrial fibrillation.|pdf=|usr=}}{{28839241}}
{{tp|p=38158807|t=2023. Transcriptomic profile of the mechanosensitive ion channelome in human cardiac fibroblasts.|pdf=|usr=}}{{38158807}}
{{tp|p=26444674|t=2015. Determinants of ventricular arrhythmias in human explanted hearts with dilated cardiomyopathy.|pdf=|usr=}}{{26444674}}
{{tp|p=19137675|t=2008. [Effect of mutations imitating the phosphorylation by TRPM7 kinase on the function of the N-terminal domain of tropomodulin].|pdf=|usr=}}{{19137675}}
{{tp|p=27614169|t=2016. Endoglin selectively modulates transient receptor potential channel expression in left and right heart failure.|pdf=|usr=}}{{27614169}}
{{tp|p=20962103|t=2011. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation.|pdf=|usr=}}{{20962103}}
{{tp|p=20735425|t=2010. Induction of a novel cation current in cardiac ventricular myocytes by flufenamic acid and related drugs.|pdf=|usr=}}{{20735425}}
{{tp|p=34831426|t=2021. Arrhythmogenic Remodeling in the Failing Heart.|pdf=|usr=}}{{34831426}}
{{tp|p=37629047|t=2023. New Therapeutics for Heart Failure: Focusing on cGMP Signaling.|pdf=|usr=}}{{37629047}}
{{tp|p=35936045|t=2022. ... Expert Consensus Statement on the state of genetic testing for cardiac diseases.|pdf=|usr=}}{{35936045}}
{{tp|p=30256393|t=2019. Mitochondrial dysfunction in human immunodeficiency virus-1 transgenic mouse cardiac myocytes.|pdf=|usr=}}{{30256393}}
{{tp|p=36738240|t=2023. Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.|pdf=|usr=}}{{36738240}}